Biopharmaceutical Expert Joins Sartorius

Dr Christel Fenge has joined the Sartorius Stedim Biotech group as Vice President of Marketing for Fermentation Technologies. She is globally responsible for managing the product portfolio of multi- and single-use bioreactors, which is said to currently represent the most comprehensive range in the industry.

Most recently Christel was General Manager of Recipharm Biologics and previous posts included senior management positions in biopharmaceutical development at AstraZeneca. She has doctorate in

Biochemistry from the University of Hanover, Germany.

“We are extremely pleased to have Dr Fenge join our organisation to strengthen our Fermentation Technology activities, particularly with regard to implementing and supporting our single-use technology

approach (in which) she will play an essential role,” explained Reinhard Vogt, Member of the Board of Sartorius Stedim Biotech. “She brings with her an exceptional experience base of cell culture and protein science, which will further our customer support and technology bases.”